1. Home
  2. NEO vs EFSC Comparison

NEO vs EFSC Comparison

Compare NEO & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • EFSC
  • Stock Information
  • Founded
  • NEO 2001
  • EFSC 1988
  • Country
  • NEO United States
  • EFSC United States
  • Employees
  • NEO N/A
  • EFSC N/A
  • Industry
  • NEO Precision Instruments
  • EFSC Major Banks
  • Sector
  • NEO Health Care
  • EFSC Finance
  • Exchange
  • NEO Nasdaq
  • EFSC Nasdaq
  • Market Cap
  • NEO 2.3B
  • EFSC 2.1B
  • IPO Year
  • NEO 1999
  • EFSC 1999
  • Fundamental
  • Price
  • NEO $14.18
  • EFSC $57.58
  • Analyst Decision
  • NEO Strong Buy
  • EFSC Strong Buy
  • Analyst Count
  • NEO 10
  • EFSC 4
  • Target Price
  • NEO $20.56
  • EFSC $56.50
  • AVG Volume (30 Days)
  • NEO 1.2M
  • EFSC 145.5K
  • Earning Date
  • NEO 02-18-2025
  • EFSC 01-27-2025
  • Dividend Yield
  • NEO N/A
  • EFSC 1.94%
  • EPS Growth
  • NEO N/A
  • EFSC N/A
  • EPS
  • NEO N/A
  • EFSC 4.72
  • Revenue
  • NEO $644,118,000.00
  • EFSC $591,631,000.00
  • Revenue This Year
  • NEO $12.98
  • EFSC N/A
  • Revenue Next Year
  • NEO $9.94
  • EFSC $0.15
  • P/E Ratio
  • NEO N/A
  • EFSC $12.24
  • Revenue Growth
  • NEO 12.06
  • EFSC N/A
  • 52 Week Low
  • NEO $12.13
  • EFSC $37.28
  • 52 Week High
  • NEO $19.11
  • EFSC $63.13
  • Technical
  • Relative Strength Index (RSI)
  • NEO 40.28
  • EFSC 53.73
  • Support Level
  • NEO $13.93
  • EFSC $55.80
  • Resistance Level
  • NEO $16.18
  • EFSC $58.62
  • Average True Range (ATR)
  • NEO 1.13
  • EFSC 1.48
  • MACD
  • NEO -0.33
  • EFSC 0.29
  • Stochastic Oscillator
  • NEO 29.37
  • EFSC 80.27

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.

Share on Social Networks: